Astrazeneca Pharma India surges on delisting proposal

Shares in Astrazeneca Pharma India Ltd surge 20 percent to their maximum daily limit after the drug maker says its board would meet on Wednesday to discuss delisting proposal.

AstraZeneca Pharma India said in the filing before markets opened on Monday that its board received a request from its promoter, AstraZeneca Pharmaceuticals AB Sweden, to initiate a voluntary delisting process.

Astrazeneca Pharmaceuticals AB holds 75 percent in AstraZeneca Pharma India.

RELATED ARTICLES

EDITORIAL OF THE DAY

  • Legalising betting on cricket will raise tax collections for cash-strapped government

    Last month, Justice RM Lodha committee on cricket reforms made several groundbreaking recommendations to the Supreme Court.

FC NEWSLETTER

Stay informed on our latest news!

TODAY'S COLUMNS

Arun Nigavekar

Tablets, memory cards for educatioNext

The Commonwealth he­ads of government mee­ting held in Malta last ...

Rajgopal Nidamboor

Try to awaken the archaeologist within

Our mind is far ahead of René Descartes’ famous maxim, ...

Dharmendra Khandal

Urbanisation is costing us our wildlife

The road transport and highways minister Nitin Gadkari aims to ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture